Trial Profile
A phase III clinical trial of rat nerve growth factor injection in the treatment of wounded optic nerve
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Nerve growth factor (Primary)
- Indications Optic nerve disorders
- Focus Registrational; Therapeutic Use
- 26 Jun 2016 Status changed from recruiting to completed.
- 14 Jan 2014 New trial record